STOCK TITAN

DocGo Inc. (NASDAQ: DCGO) gets more time to meet Nasdaq $1 bid price

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

DocGo Inc. reports that Nasdaq has granted additional time to regain compliance with the exchange’s minimum bid price rule. The company now has until January 25, 2027 to meet the Nasdaq Listing Rule 5550(a)(2) requirement that its common stock close at or above $1.00 per share for at least 10 consecutive business days. If this condition is met before the deadline, Nasdaq staff will confirm that the company has returned to compliance.

DocGo states that it will monitor its share price and evaluate options to regain compliance, including a possible reverse stock split. At the June 16, 2026 annual meeting, stockholders approved an amendment authorizing a reverse split at a ratio between 1-for-5 and 1-for-10, to be implemented at the board’s discretion.

Positive

  • None.

Negative

  • Non-compliance with Nasdaq bid rule is disclosed, with a deadline of January 25, 2027 to restore a minimum $1.00 bid price for 10 consecutive business days.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
Compliance deadline January 25, 2027 Deadline to regain compliance with Nasdaq minimum bid price requirement
Minimum bid price $1.00 per share Required closing bid price for DocGo common stock under Nasdaq Listing Rule 5550(a)(2)
Consecutive days requirement 10 business days Period DocGo’s stock must maintain at least a $1.00 closing bid to regain compliance
Extension length 180 calendar days Additional time granted by Nasdaq to regain minimum bid price compliance
Reverse split range 1-for-5 to 1-for-10 Shareholder-approved reverse stock split ratios at 2026 annual meeting
Annual meeting date June 16, 2026 Date stockholders approved reverse stock split amendment
Nasdaq Listing Rule 5550(a)(2) regulatory
"to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2)"
Minimum Bid Requirement regulatory
"to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”)"
A minimum bid requirement is a rule that a stock’s price must meet or exceed a set floor for certain market actions — for example to remain listed on an exchange, qualify for a tender offer, or participate in a specific auction. It matters to investors because falling below that floor can trigger delisting, limit who can buy or sell the shares, or change the terms of a transaction; think of it like a store’s minimum purchase needed to access a special sale, which affects value and liquidity.
reverse stock split financial
"evaluate available options to regain compliance with the Minimum Bid Requirement, including initiating a reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
continued listing rule regulatory
"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did DocGo Inc. (DCGO) announce regarding its Nasdaq listing?

DocGo Inc. reported that Nasdaq granted an additional 180 days, until January 25, 2027, to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

What is the new deadline for DCGO to regain Nasdaq bid-price compliance?

DocGo has until January 25, 2027 to regain compliance. The stock must trade with a closing bid of at least $1.00 for 10 consecutive business days within this extension period.

What is Nasdaq’s Minimum Bid Requirement affecting DocGo (DCGO)?

The Minimum Bid Requirement under Nasdaq Listing Rule 5550(a)(2) requires DocGo’s common stock to maintain a closing bid price of at least $1.00 per share for 10 consecutive business days to be in compliance.

What options is DocGo (DCGO) considering to regain Nasdaq compliance?

DocGo plans to monitor its closing bid price and will evaluate options to regain compliance, including potentially initiating a reverse stock split of its common stock if the board deems it appropriate.

What reverse stock split did DCGO shareholders authorize in 2026?

At the June 16, 2026 annual meeting, DocGo stockholders approved an amendment allowing a reverse stock split at a ratio between 1-for-5 and 1-for-10, with the exact ratio to be set by the board of directors.

Has DocGo (DCGO) already implemented a reverse stock split?

DocGo has not stated that a reverse split has been implemented. Stockholders approved authority for a reverse split between 1-for-5 and 1-for-10, and the company notes it may use this option to regain bid-price compliance.

Why is DocGo (DCGO) filing under the Nasdaq continued listing rule item?

DocGo filed under the continued listing rule item because it received notice related to failure to satisfy the minimum bid price requirement and the granting of an additional 180-day compliance period by Nasdaq.
0001822359FALSE00018223592026-07-282026-07-28


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________

FORM 8-K
___________________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): July 28, 2026
___________________________________

DOCGO INC.
(Exact name of registrant as specified in its charter)
___________________________________

Delaware
001-39618
85-2515483
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
685 Third Avenue, 9th Floor, New York, New York
10017
(Address of principal executive offices)
(Zip Code)
(844) 443-6246
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $0.0001 per share
DCGO
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On July 28, 2026, DocGo Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until January 25, 2027, to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”).

If at any time before January 25, 2027, the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), is at least $1.00 per share for a minimum of 10 consecutive business days, the Staff will provide written confirmation that the Company has achieved compliance with the Minimum Bid Requirement.

While there can be no assurance that the Company will regain compliance with the Minimum Bid Requirement prior to January 25, 2027, or maintain compliance with the other Nasdaq listing requirements, the Company intends to actively monitor the closing bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Requirement, including initiating a reverse stock split. At the Company’s 2026 Annual Meeting of Stockholders held on June 16, 2026, the Company’s stockholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10, to be determined in the sole discretion of the Company’s Board of Directors.
1


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


DOCGO INC.
By:
/s/ Norman Rosenberg
Name:
Norman Rosenberg
Title:
Chief Financial Officer and Treasurer

Date: July 30, 2026

2

Filing Exhibits & Attachments

4 documents